CENTESSA PHARMACEUTICALS (260) — Financial Flexibility Index
CENTESSA PHARMACEUTICALS (260) has a Financial Flexibility Index of -0.47x as of March 2026. Free cash flow of €-72.22 Million (operating CF €-72.22 Million minus capex €0.00) represents 0% of total liabilities (€154.41 Million). For the full cash flow conversion analysis, see CENTESSA PHARMACEUTICALS operating cash flow efficiency.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
CENTESSA PHARMACEUTICALS Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for CENTESSA PHARMACEUTICALS across 4 annual periods. Check CENTESSA PHARMACEUTICALS tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Financial Flexibility Index for CENTESSA PHARMACEUTICALS (2022–2025)
Year-by-year free cash flow to debt coverage for CENTESSA PHARMACEUTICALS. Explore 260 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.20x | €-193.45 Million | €-193.82 Million | €160.63 Million | ▼ -48.6% |
| 2024 | -0.81x | €-142.02 Million | €-142.06 Million | €175.25 Million | ▲ +37.3% |
| 2023 | -1.29x | €-160.17 Million | €-160.34 Million | €124.00 Million | ▲ +30.0% |
| 2022 | -1.84x | €-199.41 Million | €-200.55 Million | €108.14 Million | — |